Related Experiment Video

Updated: Mar 14, 2026

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter
11:32

Identification of Transcription Factor Regulators using Medium-Throughput Screening of Arrayed Libraries and a Dual-Luciferase-Based Reporter

Published on: March 27, 2020

7.5K

The transcription factor Ets21C drives tumor growth by cooperating with AP-1

Janine Toggweiler1, Maria Willecke1, Konrad Basler1

  • 1Institute of Molecular Life Sciences, University of Zurich, Zurich, Switzerland.

Scientific Reports
|October 8, 2016
PubMed

Insights

The transcription factor Ets21C is a key driver of tumor growth. Suppressing Ets21C halts tumor development, while its overexpression accelerates it, revealing a new therapeutic target.

Area of Science:

  • Molecular Biology
  • Cancer Research
  • Genetics

Background:

  • Tumorigenesis arises from genetic changes disrupting cell proliferation and death signaling pathways.
  • Understanding these complex signaling networks is crucial for developing effective cancer growth inhibitors.

Purpose of the Study:

  • To identify novel regulators of tumor growth.
  • To elucidate the role of the transcription factor Ets21C in tumorigenesis.
  • To propose a model for Ets21C's function in cancer progression.

Main Methods:

  • Depletion and ectopic expression of Ets21C in a tumor model.
  • Analysis of JNK pathway regulation of Ets21C.
  • Identification of Ets21C target genes and their regulation by AP-1.

Main Results:

  • Ets21C depletion significantly suppressed tumor growth; ectopic expression increased tumor size.
  • Ets21C expression is regulated by the JNK pathway.
  • Ets21C acts in a positive feed-forward loop, cooperating with AP-1 to activate JNK target genes essential for tumor growth.

Conclusions:

  • Ets21C is a pivotal regulator of tumor growth.
  • Ets21C plays a critical role in the JNK pathway's transcriptional program during neoplastic growth.
  • This study enhances understanding of cancer mechanisms and identifies Ets21C as a potential therapeutic target.

More Related Videos

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants07:38

Intracellular Phosphoflow Cytometry of Acute Myeloid Leukemia Patient-Derived Xenotransplants

Published on: June 6, 2025

890
Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis09:58

Mapping the Structure-Function Relationships of Disordered Oncogenic Transcription Factors Using Transcriptomic Analysis

Published on: June 27, 2020

3.2K

Related Concept Videos

mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
5.0K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

1.6K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
5.4K
Master Transcription Regulators02:23

Master Transcription Regulators

Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a  complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
8.0K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
6.1K
TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
10.8K